News & Updates

Show Multimedia Only

Prescription delivery programme helps improve HbA1c levels in patients with diabetes

22 Sep 2026

A novel prescription delivery programme (PDP) appears to significantly reduce glycated haemoglobin levels (HbA1c) in patients with diabetes mellitus (DM), suggests a study.

Prescription delivery programme helps improve HbA1c levels in patients with diabetes

22 Sep 2026

DOACs safe for kidney transplant recipients

22 Sep 2026

Among kidney transplant recipients, the risk of bleeding is comparable between patients treated with warfarin and those treated with direct oral anticoagulants (DOACs), a study has shown.

DOACs safe for kidney transplant recipients

22 Sep 2026

Bacterial lysate does little to prevent wheezing lower respiratory tract illness in children

22 Sep 2026

Oral administration of the bacterial lysate OM-85 in early life does not appear to reduce the incidence of wheezing lower respiratory tract illness during the preschool years, according to the parallel-arm, double-blind, placebo-controlled ORBEX trial.

Bacterial lysate does little to prevent wheezing lower respiratory tract illness in children

22 Sep 2026

Diuretic-induced weight loss tied to lower risk of HF rehospitalization

21 Sep 2026 by

In patients hospitalized for heart failure (HF), losing at least 2 kg of weight while receiving treatment with intravenous loop diuretic may be a good prognostic signal, being associated with reduced 30-day risk of HF rehospitalization regardless of renal function status, as shown in a study.

Diuretic-induced weight loss tied to lower risk of HF rehospitalization

21 Sep 2026

Nebivolol mends hypertension-induced endothelial cell dysfunction

21 Sep 2026 by

Treatment with nebivolol results in the improvement of hypertension-induced endothelial cell (EC) dysfunction by reducing the factors that contribute to cellular senescence of the endothelium, a study has shown.

Nebivolol mends hypertension-induced endothelial cell dysfunction

21 Sep 2026

Hormone therapy may lift mood in middle-aged women

20 Sep 2026

The use of systemic hormone therapy in women helps improve mood symptoms in midlife, regardless of prior diagnosis of a mental health condition, antidepressant use, or menopause stage, according to a study.

Hormone therapy may lift mood in middle-aged women

20 Sep 2026

Novel thyroid hormone receptor β agonist shows promise in MASH

19 Sep 2026

Treatment with the thyroid hormone receptor β agonist ALG-055009 appears to yield substantial reductions in liver fat with no relevant safety issues in patients with metabolic dysfunction-associated steatohepatitis (MASH), according to a phase IIa study.

Novel thyroid hormone receptor β agonist shows promise in MASH

19 Sep 2026

Folic acid may offer protection in ASM-exposed pregnancies

18 Sep 2026 by

Supplementation with high-dose folic acid appears beneficial to pregnant women with epilepsy being treated with antiseizure medications (ASMs), having been associated with a lower incidence of adverse offspring outcomes in an observational study from China.

Folic acid may offer protection in ASM-exposed pregnancies

18 Sep 2026

Long-term bulevirtide treatment safe, effective for chronic hepatitis D

17 Sep 2026 by

Treatment with bulevirtide monotherapy for up to 144 weeks is safe, well tolerated, and effective in patients with chronic hepatitis D (CHD), a study has shown.

Long-term bulevirtide treatment safe, effective for chronic hepatitis D

17 Sep 2026

Novel glucagon/GLP-1 receptor dual agonist helps reduce liver fat

17 Sep 2026

In patients with metabolic dysfunction-associated steatotic liver disease or steatohepatitis, treatment with the novel glucagon and GLP-1 receptor dual agonist DD01 is associated with rapid reductions in liver fat, according to a phase II study.

Novel glucagon/GLP-1 receptor dual agonist helps reduce liver fat

17 Sep 2026

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Prescription delivery programme helps improve HbA1c levels in patients with diabetes

Prescription delivery programme helps improve HbA1c levels in patients with diabetes

DOACs safe for kidney transplant recipients

DOACs safe for kidney transplant recipients

Bacterial lysate does little to prevent wheezing lower respiratory tract illness in children

Bacterial lysate does little to prevent wheezing lower respiratory tract illness in children

Diuretic-induced weight loss tied to lower risk of HF rehospitalization

Diuretic-induced weight loss tied to lower risk of HF rehospitalization

Nebivolol mends hypertension-induced endothelial cell dysfunction

Nebivolol mends hypertension-induced endothelial cell dysfunction

Hormone therapy may lift mood in middle-aged women

Hormone therapy may lift mood in middle-aged women

Novel thyroid hormone receptor β agonist shows promise in MASH

Novel thyroid hormone receptor β agonist shows promise in MASH

Folic acid may offer protection in ASM-exposed pregnancies

Folic acid may offer protection in ASM-exposed pregnancies

Long-term bulevirtide treatment safe, effective for chronic hepatitis D

Long-term bulevirtide treatment safe, effective for chronic hepatitis D

Novel glucagon/GLP-1 receptor dual agonist helps reduce liver fat

Novel glucagon/GLP-1 receptor dual agonist helps reduce liver fat